Haldorsen IS - Search Results

1

Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.

Berg A, Fasmer KE, Mauland KK, Ytre-Hauge S, Hoivik EA, Husby JA, Tangen IL, Trovik J, Halle MK, Woie K, Bjørge L, Bjørnerud A, Salvesen HB, Werner HM, Krakstad C, Haldorsen IS. Berg A, et al. Among authors: haldorsen is. Oncotarget. 2016 Oct 25;7(43):69844-69856. doi: 10.18632/oncotarget.12004. Oncotarget. 2016. PMID: 27634881 Free PMC article.

2

Double reading of radiological examinations in Norway.

Husby JA, Espeland A, Kalyanpur A, Brocker C, Haldorsen IS. Husby JA, et al. Among authors: haldorsen is. Acta Radiol. 2011 Jun 1;52(5):516-21. doi: 10.1258/ar.2011.100347. Epub 2011 Mar 17. Acta Radiol. 2011. PMID: 21498308

3

Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques.

Haldorsen IS, Salvesen HB. Haldorsen IS, et al. Clin Radiol. 2012 Jan;67(1):2-12. doi: 10.1016/j.crad.2011.02.018. Epub 2011 Nov 25. Clin Radiol. 2012. PMID: 22119292 Review.

4

Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists.

Haldorsen IS, Husby JA, Werner HM, Magnussen IJ, Rørvik J, Helland H, Trovik J, Salvesen ØO, Espeland A, Salvesen HB. Haldorsen IS, et al. Eur Radiol. 2012 Jul;22(7):1601-11. doi: 10.1007/s00330-012-2400-y. Epub 2012 Mar 28. Eur Radiol. 2012. PMID: 22453859

5

Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas.

Haldorsen IS, Berg A, Werner HM, Magnussen IJ, Helland H, Salvesen OO, Trovik J, Salvesen HB. Haldorsen IS, et al. Gynecol Oncol. 2012 Sep;126(3):413-8. doi: 10.1016/j.ygyno.2012.05.009. Epub 2012 May 15. Gynecol Oncol. 2012. PMID: 22609110

6

Markers for individualised therapy in endometrial carcinoma.

Salvesen HB, Haldorsen IS, Trovik J. Salvesen HB, et al. Among authors: haldorsen is. Lancet Oncol. 2012 Aug;13(8):e353-61. doi: 10.1016/S1470-2045(12)70213-9. Lancet Oncol. 2012. PMID: 22846840 Review.

7

Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence.

Haldorsen IS, Grüner R, Husby JA, Magnussen IJ, Werner HM, Salvesen OO, Bjørge L, Stefansson I, Akslen LA, Trovik J, Taxt T, Salvesen HB. Haldorsen IS, et al. Eur Radiol. 2013 Oct;23(10):2916-25. doi: 10.1007/s00330-013-2901-3. Epub 2013 Jun 4. Eur Radiol. 2013. PMID: 23732687 Clinical Trial.

8

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas.

Haldorsen IS, Stefansson I, Grüner R, Husby JA, Magnussen IJ, Werner HM, Salvesen ØO, Bjørge L, Trovik J, Taxt T, Akslen LA, Salvesen HB. Haldorsen IS, et al. Br J Cancer. 2014 Jan 7;110(1):107-14. doi: 10.1038/bjc.2013.694. Epub 2013 Oct 31. Br J Cancer. 2014. PMID: 24178757 Free PMC article.

9

Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.

Ytre-Hauge S, Husby JA, Magnussen IJ, Werner HM, Salvesen ØO, Bjørge L, Trovik J, Stefansson IM, Salvesen HB, Haldorsen IS. Ytre-Hauge S, et al. Among authors: haldorsen is. Int J Gynecol Cancer. 2015 Mar;25(3):459-66. doi: 10.1097/IGC.0000000000000367. Int J Gynecol Cancer. 2015. PMID: 25628109 Free PMC article.

10

Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas.

Husby JA, Salvesen ØO, Magnussen IJ, Trovik J, Bjørge L, Salvesen HB, Haldorsen IS. Husby JA, et al. Among authors: haldorsen is. Clin Radiol. 2015 May;70(5):487-94. doi: 10.1016/j.crad.2014.12.016. Epub 2015 Jan 30. Clin Radiol. 2015. PMID: 25639620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page